<collection><source>PMC</source><date>20201214</date><key>pmc.key</key><document><id>29097</id><infon key="license">NO-CC CODE</infon><passage><infon key="article-id_pmc">29097</infon><infon key="article-id_pmid">11208257</infon><infon key="article-id_publisher-id">1471-2180-1-1</infon><infon key="fpage">1</infon><infon key="journal-title">BMC Microbiology</infon><infon key="lpage">1</infon><infon key="name_0">surname:Gallaher;given-names:William R</infon><infon key="name_1">surname:DiSimone;given-names:Christopher</infon><infon key="name_2">surname:Buchmeier;given-names:Michael J</infon><infon key="section_type">TITLE</infon><infon key="type">front</infon><infon key="volume">1</infon><infon key="year">2001</infon><offset>0</offset><text>The viral transmembrane superfamily: possible divergence of Arenavirus and Filovirus glycoproteins from a common RNA virus ancestor</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>132</offset><text>What is the background on this?</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>143</offset><text>Viral entry proteins from different viruses, such as influenza, measles, human immunodeficiency virus, type 1 (HIV-1), and Ebola virus have been found to share a coiled-coil type of entry protein, according to recent studies using molecular modeling and X-ray crystallographic or other biophysical studies.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>446</offset><text>What are the outcomes?</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>454</offset><text>GP-2 structural models of the transmembrane glycoproteins (LCMV) and Lassa fever virus are presented, with consistent structural similarities despite variation in amino acid sequence. The model includes a hydrophobic amino terminus and two antiparallel helices separated by pythons from different families of enveloped RNA viruses. This model features heptad repeat patterns that mediate multimerization through coiled-coil interactions, as well as 80% and 50% identicality to Ebolas</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>1556</offset><text>Remarkable conclusions</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>1568</offset><text>These findings suggest that a common pattern of structure and function is shared among viral transmembrane fusion proteins from different virus families, which could lead to the development of'superfluid' viruses or superfamily members.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>1817</offset><text>For the last two decades, the field of virology has been developing models that enable us to understand the evolution of viral and host proteins by observing the sequence of their proteins. These models attempt to account for the presence of a common ancestor between viruses and their hosts. This common ancestor may have emerged from a common ancestor, or it may have arisen as a minor difference between the two viruses. However, the origins of viruses and their hosts are constantly changing, and the origin of the common ancestor is always unknown.

In this article, we discuss a potential evolutionary scenario that could explain the divergence of Arenavirus and Filovirus glycoproteins from a common RNA virus ancestor. The authors discuss the evolutionary implications of this scenario in relation to the</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>1828</offset><text>A number of laboratories have found that the transmembrane (TM) proteins of several RNA viruses contain shared structural and functional elements that are essential for virus entry, such as a hydrophobic region designated as "fusion peptide" and fibrous structure defined by two antiparallel alpha helices. These principles can also be used to describe other viral infections, including Ebola and Rous sarcoma viruses, where there is significant sequence identity within some isolated viruses or even within broader family structures like the Retroviridae. However,</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>2999</offset><text>A general model of the Arenavirus glycoproteins has been proposed, which is based on the detailed study of LCMV and influenza viruses. The GP-C precursor is proteolytically cleaved to form gp-1 and PG-2, with CGPM being one of them.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>3578</offset><text>Here, we present a detailed model of GP-2 for Lassa fever virus, an Arenavirus associated with multiple epidemics of hemorrhagic fever with high mortality rates in West Africa, as well as for the related lymphocytic choriomeningitis virus (LCMV) which has been associated to sporadic outbreaks human disease in Europe and North America; this model shows that several different regions of the TM superfamily of Organismoviruses share specific sequence and structural motifs, showing that these regions are directly correlate relationships with E</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_1</infon><offset>4355</offset><text>Results and Discussion</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>4378</offset><text>The detailed model of LCM and Lassa fever virus GP-2 is shown in Figure 1. As shown previously for other members of the TM superfamily, both consist of two antiparallel helices separated by a disulfide-linked apex. The sequence of GP-2 contains a highly conserved hydrophobic sequence, LAGTFTWTL (in LCM) or LLGTFTWTL (in Lassa), in the vicinity of the post-translational cleavage site, with a canonical fusion tripeptide Gly-X-Phe. However, its candidacy as a functional fusion peptide, analogous to those of influenza, measles and HIV-1, has been questioned due to its weakly hydrophobic character and the fact that actual cleavage occurs, as shown in the models, not at the dibasic amino acids but within the hydrophobic site. LCM virus does employ an acid dependent fusion event to enter the cell but virion-cell fusion is inactive above pH 6, and the Arenaviruses have never been demonstrated to exhibit cell-cell fusion. While this amino-terminus may not be a good candidate for a classical fusion peptide, its hydrophobic nature and position suggest that it may at least be the vestige of one.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>5479</offset><text>The region prior to the first helix consists first of a glycine-serine rich linker, and then a domain that is highly conserved among all Arenaviruses and contains four cysteines. Only the last of these four is conserved between the Filoviruses and Arenaviruses. We have not assigned disulfide linkages for these since there are neither data nor parallels with other viruses to permit such assignments. Since there is no disulfide cross-linkage with GP-1, these must participate in disulfide bonding within the same GP-2 protein, or in cross-linking GP-2 oligomers. The latter possibility is suggested by the kinetics of GP-2 association with experimental addition of reducing agent, indicating first a change in vitro from tetramers to dimers and then to monomers only after considerable additional reduction. Whether the native multimeric form of GP-2 in the virion may be a trimer, as for the fusion glycoproteins of Retroviruses or Filoviruses, is yet to be determined.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>6452</offset><text>The amino-terminal helices of both consist of extended amphipathic arrays with strong heptad repeats that have been previously noted, and are thought to form the backbone of the coiled-coil stalk of the viral glycoprotein complex A peptide analogue of this extended heptad repeat in LCMV, GP-C 326-355, was examined by circular dichroism under different solvent conditions, as shown in Table 1. The peptide exhibited only limited helicity in aqueous solution, but 79% alpha helix in a neutral hydrophobic environment. This biophysical behavior is reminiscent of that of other similar peptides derived from the corresponding sequences of Paramyxoviral or Retroviral TM proteins.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>7130</offset><text>Comparison of the sequences of Lassa and LCM over this amphipathic heptad-repeat region (below) shows 31 identical of 58 amino acids, with the principal areas of conservation of sequence at the amino- and carboxy-terminal ends of the amphipathic helix.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>7383</offset><text>The middle 25 amino acids appear poorly conserved, with only 6 of 25 identical, yet the character of the amino acids substituted is generally conserved. In particular, while none of the central 4 heptad amino acids (underlined and in bold) are identical in each virus, in all cases the hydrophobic character of the heptad repeat is maintained.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>7727</offset><text>The apical domain is the only region to be glycosylated, also in line with a number of TM proteins including that of HIV-1 and other Retroviruses. The apical sequence, particularly the peptide KFWYL in LCMV or KYWYL in Lassa, defines a broadly-cross reactive antibody epitope shared by these viruses that is in precisely the same topographical location as the broadly-reactive apical epitope (positions 598-609, LGIWGCSGKLIC) that has been finely mapped in HIV-1. Also like that in HIV-1, it is responsive to multimer conformation, and increasingly exposed after receptor binding that results in release of the binding subunit, GP-1.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>8361</offset><text>The second helical region has properties similar to that of the Retroviruses and Filoviruses, in that it is highly charged (30%) and amphipathic, with its helicity possibly stabilized by multiple ion pairings of acidic and basic residues, as first noted for the corresponding region of HIV-1 </text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>8654</offset><text>Although Lassa fever and Ebola viruses represent different virus families, both helices share an unexpectedly high sequence homology. The first lies in the amino-terminal half of the extended amphipathic helix. As shown in a concentric helical wheel projection in Figure 2A, when the helices are oriented with respect to the exclusion of charge and the heptad repeats for each sequence, 9 identical or highly similar amino acids (50%) may be aligned in each sequence.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>9122</offset><text>The carboxy-terminal helical region also has properties in common with the similarly located helices in both Lassa and Ebola, shown as a concentric helical wheel projection in Figure 2B. Again, orienting the helix with respect to the hemicylindrical exclusion of charge, 9 identical or highly similar amino acids (50%) may be aligned. Furthermore, none of the amino acid differences represent a radical change of one sequence from the other.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>9564</offset><text>Arenaviruses therefore share with a number of other virus families a fusion/entry protein GP-2 that appears to have the four cardinal structural features typical of proteins in the viral transmembrane entry protein superfamily. Our model of the extramembranal portion of GP-2 begins with a hydrophobic fusion peptide sequence, followed by two antiparallel extended helices, the first of which contains a strong heptad repeat sequence, which lie on either side of a disulfide-stabilized, glycosylated and strongly antigenic reverse turn. These features have been apparently maintained in spite of diversity in primary amino acid sequence within the Arenavirus family.</text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">title_1</infon><offset>10231</offset><text>Remarkable conclusions</text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">paragraph</infon><offset>10243</offset><text>Due to the similarities in their agents, it is probable that they both derive from a common viral ancestor, as evidenced by the type of each Arenavirus found in large areas and the stability of isolates within confined areas over time. This suggests that the conservation of such peptide sequences could be significant in the biology of these agents.</text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">paragraph</infon><offset>10979</offset><text>Modeling studies conducted in the late 1980s have identified several common and homologous sequence motifs for infection that were not previously recognized in sequence homology studies. These models may now offer a universally applicable approach to antiviral inhibition of virus entry into host cells, which is applicable to various virus families.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_1</infon><offset>11418</offset><text>Materials and Methods</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>11440</offset><text>Molecular Modeling</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>11459</offset><text>Sequences used for this analysis were LCMV - ARM (Genbank P09991) and Lassa, Josiah (Genbank P08669), and are numbered from the initiation methionine. Detailed models of the Arenavirus GP-1 proteins were determined by the methods of Gallaher et al. previously described A consensus of several independent structural algorithms is used, and compared for different GP-2 sequences to test the consensus. The resulting model is an average consensus of the algorithms for these two sequences. Models are projected in helical net or helical wheel projections also as previously described.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>12042</offset><text>Peptide Synthesis and Circular Dichroism</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>12083</offset><text>A peptide corresponding to amino acid positions 326-355 of LCMV-ARM-4 (Genbank VGXPLM) in single letter code, NKAALSKFKEDVESALHLFKTTVNSLISDQ, with an additional histidine at the N terminus was synthesized by standard BOC chemistry using double coupling and HF cleavage. The peptide was purified by reverse phase HPLC on a C-18 column and the peptide's weight confirmed by mass spectroscopy. The peptide was selected as predicted by the Lupas algorithm to have a greater than 90% probability of forming a heptad repeat in the native protein structure. Peptide samples for circular dichroism (CD) were prepared at 0.1 mg/ml concentrations in either 1 mM NaCO3, pH 7.2 (Neutral) or in 100 mM MES, pH 5.5 (Acid). In spectra recorded with TFE, the TFE was present as 45% of solution volume. CD spectra were recorded from 300-180 nm with 0.5 nm steps with a pathlength of 0.1 cm and at 4&#176;C. Final values were determined using the average of 15 spectra which were correlated with baseline spectra of buffer samples. A characteristic alpha helical spectrum was apparent for the peptide when placed in TFE with a positive peak at 195 nm (&#920; = +43000) and a second minimum peak at 210 nm (&#920; = -25000).</text></passage><passage><infon key="fpage">366</infon><infon key="lpage">373</infon><infon key="name_0">surname:Wilson;given-names:IA</infon><infon key="name_1">surname:Skehel;given-names:JJ</infon><infon key="name_2">surname:Wiley;given-names:DC</infon><infon key="pub-id_pmid">7464906</infon><infon key="section_type">REF</infon><infon key="source">Nature</infon><infon key="type">ref</infon><infon key="volume">289</infon><infon key="year">1981</infon><offset>13282</offset><text>Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution.</text></passage><passage><infon key="fpage">2186</infon><infon key="lpage">2191</infon><infon key="name_0">surname:Lambert;given-names:DM</infon><infon key="name_1">surname:Barney;given-names:S</infon><infon key="name_2">surname:Lambert;given-names:AL</infon><infon key="name_3">surname:Guthrie;given-names:K</infon><infon key="name_4">surname:Medinas;given-names:R</infon><infon key="name_5">surname:Davis;given-names:DE</infon><infon key="name_6">surname:Bucy;given-names:T</infon><infon key="name_7">surname:Erickson;given-names:J</infon><infon key="name_8">surname:Merutka;given-names:G</infon><infon key="name_9">surname:Petteway;given-names:SR;suffix:Jr</infon><infon key="pub-id_pmid">8700906</infon><infon key="section_type">REF</infon><infon key="source">Proc Nat Acad Sci USA</infon><infon key="type">ref</infon><infon key="volume">93</infon><infon key="year">1996</infon><offset>13374</offset><text>Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.</text></passage><passage><infon key="fpage">431</infon><infon key="lpage">440</infon><infon key="name_0">surname:Gallaher;given-names:WR</infon><infon key="name_1">surname:Ball;given-names:JM</infon><infon key="name_2">surname:Garry;given-names:RF</infon><infon key="name_3">surname:Griffin;given-names:MC</infon><infon key="name_4">surname:Montelaro;given-names:RC</infon><infon key="pub-id_pmid">2788443</infon><infon key="section_type">REF</infon><infon key="source">AIDS Res Human Retroviruses</infon><infon key="type">ref</infon><infon key="volume">5</infon><infon key="year">1989</infon><offset>13482</offset><text>A general model for the transmembrane proteins of HIV and other retroviruses.</text></passage><passage><infon key="fpage">477</infon><infon key="lpage">478</infon><infon key="name_0">surname:Gallaher;given-names:WR</infon><infon key="pub-id_pmid">8653783</infon><infon key="section_type">REF</infon><infon key="source">Cell</infon><infon key="type">ref</infon><infon key="volume">85</infon><infon key="year">1996</infon><offset>13560</offset><text>Similar structural models of the transmembrane proteins of Ebola and avian sarcoma viruses.</text></passage><passage><infon key="fpage">3</infon><infon key="lpage">9</infon><infon key="name_0">surname:Weissenhorn;given-names:W</infon><infon key="name_1">surname:Dessen;given-names:A</infon><infon key="name_2">surname:Calder;given-names:LJ</infon><infon key="name_3">surname:Harrison;given-names:SC</infon><infon key="name_4">surname:Skehel;given-names:JJ</infon><infon key="name_5">surname:Wiley;given-names:DC</infon><infon key="pub-id_pmid">10332732</infon><infon key="section_type">REF</infon><infon key="source">Molecular Membrane Biology</infon><infon key="type">ref</infon><infon key="volume">16</infon><infon key="year">1999</infon><offset>13652</offset><text>Structural basis for membrane fusion by enveloped viruses.</text></passage><passage><infon key="fpage">605</infon><infon key="lpage">616</infon><infon key="name_0">surname:Weissenhorn;given-names:W</infon><infon key="name_1">surname:Carfi;given-names:A</infon><infon key="name_2">surname:Lee;given-names:KH</infon><infon key="name_3">surname:Skehel;given-names:JJ</infon><infon key="name_4">surname:Wiley;given-names:DC</infon><infon key="pub-id_pmid">9844633</infon><infon key="section_type">REF</infon><infon key="source">Molecular Cell</infon><infon key="type">ref</infon><infon key="volume">2</infon><infon key="year">1998</infon><offset>13711</offset><text>Crystal structure of the Ebola virus membrane fusion subunit, GP2, from the envelope glycoprotein ectodomain.</text></passage><passage><infon key="fpage">175</infon><infon key="lpage">83</infon><infon key="name_0">surname:Wright;given-names:KE</infon><infon key="name_1">surname:Spiro;given-names:RC</infon><infon key="name_2">surname:Burns;given-names:JW</infon><infon key="name_3">surname:Buchmeier;given-names:MJ</infon><infon key="pub-id_pmid">2141203</infon><infon key="section_type">REF</infon><infon key="source">Virology</infon><infon key="type">ref</infon><infon key="volume">177</infon><infon key="year">1990</infon><offset>13821</offset><text>Post-translational processing of the glycoproteins of lymphocytic choriomeningitis virus.</text></passage><passage><infon key="fpage">620</infon><infon key="lpage">629</infon><infon key="name_0">surname:Burns;given-names:JW</infon><infon key="name_1">surname:Buchmeier;given-names:MJ</infon><infon key="pub-id_pmid">1853564</infon><infon key="section_type">REF</infon><infon key="source">Virology</infon><infon key="type">ref</infon><infon key="volume">183</infon><infon key="year">1991</infon><offset>13911</offset><text>Protein-protein interactions in lymphocytic choriomeningitis virus.</text></passage><passage><infon key="fpage">3</infon><infon key="lpage">9</infon><infon key="name_0">surname:Di Simone;given-names:C</infon><infon key="name_1">surname:Buchmeier;given-names:MJ</infon><infon key="pub-id_pmid">7747483</infon><infon key="section_type">REF</infon><infon key="source">Virology</infon><infon key="type">ref</infon><infon key="volume">209</infon><infon key="year">1995</infon><offset>13979</offset><text>Kinetics and pH dependence of acid-induced structural changes in the lymphocytic choriomeningitis virus glycoprotein complex.</text></passage><passage><infon key="fpage">7270</infon><infon key="lpage">7281</infon><infon key="name_0">surname:Borrow;given-names:P</infon><infon key="name_1">surname:Oldstone;given-names:MB</infon><infon key="pub-id_pmid">1331520</infon><infon key="section_type">REF</infon><infon key="source">J Virol</infon><infon key="type">ref</infon><infon key="volume">66</infon><infon key="year">1992</infon><offset>14105</offset><text>Characterization of lymphocytic choriomeningitis virus-binding protein(s): a candidate cellular receptor for the virus.</text></passage><passage><infon key="fpage">670</infon><infon key="lpage">676</infon><infon key="name_0">surname:Frame;given-names:JD</infon><infon key="name_1">surname:Baldwin;given-names:JM;suffix:Jr</infon><infon key="name_2">surname:Gocke;given-names:DJ</infon><infon key="name_3">surname:Troup;given-names:JM</infon><infon key="pub-id_pmid">4246571</infon><infon key="section_type">REF</infon><infon key="source"> Am J Trop Med Hyg</infon><infon key="type">ref</infon><infon key="volume">19</infon><infon key="year">1970</infon><offset>14225</offset><text>Lassa fever, a new virus disease of man from West Africa. I. Clinical description and pathological findings.</text></passage><passage><infon key="fpage">1521</infon><infon key="lpage">1551</infon><infon key="name_0">surname:Peters;given-names:CJ</infon><infon key="name_1">surname:Buchmeier;given-names:MJ</infon><infon key="name_2">surname:Rollin;given-names:PE</infon><infon key="name_3">surname:Ksiazek;given-names:TG</infon><infon key="section_type">REF</infon><infon key="source">In Virology; third Edition Edited by BN Fields, et al Lippincott-Raven,</infon><infon key="type">ref</infon><infon key="year">1996</infon><offset>14334</offset><text>Arenaviruses (Chapter 50).</text></passage><passage><infon key="fpage">455</infon><infon key="lpage">465</infon><infon key="name_0">surname:Di Simone;given-names:C</infon><infon key="name_1">surname:Zandonatti;given-names:MA</infon><infon key="name_2">surname:Buchmeier;given-names:MJ</infon><infon key="pub-id_pmid">8291229</infon><infon key="section_type">REF</infon><infon key="source">Virology</infon><infon key="type">ref</infon><infon key="volume">198</infon><infon key="year">1994</infon><offset>14361</offset><text>Acidic pH triggers LCMV membrane fusion activity and conformational change in the glycoprotein spike.</text></passage><passage><infon key="fpage">11418</infon><infon key="lpage">11421</infon><infon key="name_0">surname:Lenz;given-names:O</infon><infon key="name_1">surname:ter Meulen;given-names:J</infon><infon key="name_2">surname:Feldmann;given-names:H</infon><infon key="name_3">surname:Klenk;given-names:H-D</infon><infon key="name_4">surname:Garten;given-names:W</infon><infon key="pub-id_pmid">11070044</infon><infon key="section_type">REF</infon><infon key="source">J Virol</infon><infon key="type">ref</infon><infon key="volume">74</infon><infon key="year">2000</infon><offset>14463</offset><text>Identification of a novel consensus sequence at the cleavage site of the Lassa virus glycoprotein.</text></passage><passage><infon key="fpage">3075</infon><infon key="lpage">3080</infon><infon key="name_0">surname:Chambers;given-names:P</infon><infon key="name_1">surname:Pringle;given-names:CR</infon><infon key="name_2">surname:Easton;given-names:AJ</infon><infon key="pub-id_pmid">2177097</infon><infon key="section_type">REF</infon><infon key="source">J Gen Virol</infon><infon key="type">ref</infon><infon key="volume">71</infon><infon key="year">1990</infon><offset>14562</offset><text>Heptad repeat sequences are located adjacent to hydrophobic regions in several types of virus fusion glycoproteins.</text></passage><passage><infon key="fpage">17</infon><infon key="lpage">35</infon><infon key="name_0">surname:Burns;given-names:J.W.</infon><infon key="name_1">surname:Buchmeier;given-names:M.J.</infon><infon key="section_type">REF</infon><infon key="source">In The Arenaviridae Edited by MS Salvato Plenum Press,</infon><infon key="type">ref</infon><infon key="year">1993</infon><offset>14678</offset><text>Glycoproteins of the Arenaviruses.</text></passage><passage><infon key="fpage">12676</infon><infon key="lpage">12680</infon><infon key="name_0">surname:Wild;given-names:C</infon><infon key="name_1">surname:Dubay;given-names:JW</infon><infon key="name_2">surname:Greenwell;given-names:T</infon><infon key="name_3">surname:Baird;given-names:T;suffix:Jr</infon><infon key="name_4">surname:Oas;given-names:TG</infon><infon key="name_5">surname:McDanal;given-names:C</infon><infon key="name_6">surname:Hunter;given-names:E</infon><infon key="name_7">surname:Matthews;given-names:T</infon><infon key="pub-id_pmid">7809100</infon><infon key="section_type">REF</infon><infon key="source">Proc Nat Acad Sci USA</infon><infon key="type">ref</infon><infon key="volume">91</infon><infon key="year">1994</infon><offset>14713</offset><text>Propensity for a leucine zipper-like domain of human immunodeficiency virus type 1 gp41 to form oligomers correlates with a role in virus-induced fusion rather than assembly of the glycoprotein complex.</text></passage><passage><infon key="fpage">30</infon><infon key="lpage">38</infon><infon key="name_0">surname:Weber;given-names:EL</infon><infon key="name_1">surname:Buchmeier;given-names:MJ</infon><infon key="pub-id_pmid">2452517</infon><infon key="section_type">REF</infon><infon key="source">Virology</infon><infon key="type">ref</infon><infon key="volume">164</infon><infon key="year">1988</infon><offset>14916</offset><text>Fine mapping of a peptide sequence containing an antigenic site conserved among arenaviruses.</text></passage><passage><infon key="fpage">2639</infon><infon key="lpage">2641</infon><infon key="name_0">surname:Gnann;given-names:JW;suffix:Jr</infon><infon key="name_1">surname:Nelson;given-names:JA</infon><infon key="name_2">surname:Oldstone;given-names:MB</infon><infon key="pub-id_pmid">2439707</infon><infon key="section_type">REF</infon><infon key="source"> J Virol</infon><infon key="type">ref</infon><infon key="volume">61</infon><infon key="year">1987</infon><offset>15010</offset><text>Fine mapping of an immunodominant domain in the transmembrane glycoprotein of human immunodeficiency virus.</text></passage><passage><infon key="fpage">1051</infon><infon key="lpage">1053</infon><infon key="name_0">surname:Wild;given-names:C</infon><infon key="name_1">surname:Greenwell;given-names:T</infon><infon key="name_2">surname:Matthews;given-names:T</infon><infon key="pub-id_pmid">8312047</infon><infon key="section_type">REF</infon><infon key="source">AIDS Res Human Retroviruses</infon><infon key="type">ref</infon><infon key="volume">9</infon><infon key="year">1993</infon><offset>15118</offset><text>A synthetic peptide from HIV-1 gp41 is a potent inhibitor of virus-mediated cell-cell fusion.</text></passage><passage><infon key="fpage">191</infon><infon key="lpage">202</infon><infon key="name_0">surname:Gallaher;given-names:WR</infon><infon key="name_1">surname:Ball;given-names:JM</infon><infon key="name_2">surname:Garry;given-names:RF</infon><infon key="name_3">surname:Martin-Amedee;given-names:AM</infon><infon key="name_4">surname:Montelaro;given-names:RC</infon><infon key="pub-id_pmid">7742034</infon><infon key="section_type">REF</infon><infon key="source">AIDS Res Human Retroviruses</infon><infon key="type">ref</infon><infon key="volume">11</infon><infon key="year">1995</infon><offset>15212</offset><text>A general model for the surface glycoproteins of HIV and other retroviruses.</text></passage><passage><infon key="fpage">1162</infon><infon key="lpage">1164</infon><infon key="name_0">surname:Lupas;given-names:A</infon><infon key="name_1">surname:Van Dyke;given-names:M</infon><infon key="name_2">surname:Stock;given-names:J</infon><infon key="pub-id_pmid">2031185</infon><infon key="section_type">REF</infon><infon key="source">Science</infon><infon key="type">ref</infon><infon key="volume">252</infon><infon key="year">1991</infon><offset>15289</offset><text>Predicting coiled coils from protein sequences.</text></passage><passage><infon key="section_type">FIG</infon><infon key="type">title_1</infon><offset>15337</offset><text>Figures and Tables</text></passage><passage><infon key="file">1471-2180-1-1-1.jpg</infon><infon key="id">F1</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>15356</offset><text>Models of the Transmembrane Proteins GP-2 of Lassa Virus and LCMV. Projections of the model structure for GP-2 of Lassa and LCMV are shown in parallel with one another, based on the consensus structures for algorithms of both viral amino acid sequences. Proposed helices are shown in helical net projection with sequential amino acids connected by solid lines. Proposed disulfide linkages are indicated by double lines. Hydrophobic amino acids are grouped with a solid background; neutral amino acids with a heavily outlined circle; hydrophilic amino acids with a light circle; glycosylation sites indicated by tridents. A heavy solid line indicates the point of proteolytic cleavage of the GP-C precursor protein to yield GP-1 and GP-2. Cysteines are highlighted by larger red circles. The surface membrane of the virus is indicated by a solid purple rectangle, the amino-terminal hydrophobic region by a yellow rectangle, and the conserved B-cell epitope by a blue rectangle. The two proposed antiparallel helices are labeled "AmphiHelix" for the extended heptad repeat, and "CPI Helix" for the charged, pre-insertion helix.</text></passage><passage><infon key="file">1471-2180-1-1-2.jpg</infon><infon key="id">F2</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>16483</offset><text>Concentric Helical Wheel Projections of Proposed Lassa and Ebola Helices. Helical wheel projections are shown for 18 amino acid segments of the proposed helices of Lassa and Ebola viruses. The projections are arranged concentrically to align the viral sequences, with the inner sequence that from Lassa virus, and the outer sequence from Ebola. Zaire virus (Genbank U31033). Rectangles indicate identical or highly similar residues in each sequence. Heavy lines indicate the hemicylinder of charge exclusion (hydrophobic) subtending an angle of 160&#176; in each alignment. Below each wheel projection the linear sequences are also aligned to show the identities (solid lines) and high similarities (dotted lines). A. Concentric alignment of the amino terminal amphipathic helices ("lower amphi") of Lassa (amino acids 309-326, in wheel positions 1-18 respectively) and Ebola (555-572). B. Concentric alignment of the charged, pre-insertion helices ("CPI Helix") of Lassa (398-415) and Ebola (618-635).</text></passage><passage><infon key="file">T1.xml</infon><infon key="id">T1</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>17482</offset><text>Circular Dichroism Spectroscopy of Peptide GPC 326-355</text></passage><passage><infon key="file">T1.xml</infon><infon key="id">T1</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version="1.0" encoding="UTF-8"?&gt;
&lt;table frame="hsides" rules="groups"&gt;&lt;thead&gt;&lt;tr&gt;&lt;td/&gt;&lt;td/&gt;&lt;td align="center"&gt;&#920;&lt;sup&gt;222&lt;/sup&gt; (deg cm&lt;sup&gt;2&lt;/sup&gt; dmol&lt;sup&gt;-1&lt;/sup&gt;)&lt;/td&gt;&lt;td align="center"&gt;% alpha helicity (100%=32,000)&lt;/td&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align="left"&gt;Aqueous&lt;/td&gt;&lt;td align="left"&gt;Neutral&lt;/td&gt;&lt;td align="center"&gt;4523&lt;/td&gt;&lt;td align="center"&gt;14.1&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="left"&gt;Acid&lt;/td&gt;&lt;td align="center"&gt;3777&lt;/td&gt;&lt;td align="center"&gt;11.8&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;TFE&lt;/td&gt;&lt;td align="left"&gt;Neutral&lt;/td&gt;&lt;td align="center"&gt;25314&lt;/td&gt;&lt;td align="center"&gt;79.1&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="left"&gt;Acid&lt;/td&gt;&lt;td align="center"&gt;11565&lt;/td&gt;&lt;td align="center"&gt;36.1&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>17537</offset><text>		&#920;222 (deg cm2 dmol-1)	% alpha helicity (100%=32,000)	 	Aqueous	Neutral	4523	14.1	 		Acid	3777	11.8	 	TFE	Neutral	25314	79.1	 		Acid	11565	36.1	 	</text></passage><passage><infon key="file">T1.xml</infon><infon key="id">T1</infon><infon key="section_type">TABLE</infon><infon key="type">table_foot</infon><offset>17689</offset><text>Circular Dichroism and calculated per cent alpha helix for the peptide derived from the LCM sequence NKAALSKFKEDVESALHLFKTTVNSLISDQ, as described in Materials and Methods.</text></passage></document></collection>